Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.

In a 2016 column to readers announcing his second cancer diagnosis ... Bundy, who spent 13 years as the Journal Star's editor, died Sunday. He was 57. "The entire Journal Star and Lee Enterprises ...

Body size and excess weight, conventionally assessed using body mass index (BMI), are well-established risk factors for many types of cancer. However, new research to be presented at this year’s ...

The public has a right to know their risk when and if they choose to drink. Such labeling has precedents with that on tobacco ...

Measles is an extremely contagious vaccine-preventable disease that can lead to death or disability. It also wipes out immune ...

Experts predict that death rates from breast cancer will fall in 2025 in every age group in the EU and the UK apart from in EU patients aged 80 years and older. In these older patients, overall ...

Information on molecular characterisation and treatments received was unavailable in the study, as European cancer registries do not systematically collect it. Additionally, a high proportion of ...

Britain's foreign secretary David Lammy, alongside his counterparts from France, Germany and Italy, have said they support an Arab-backed plan for the reconstruction of Gaza. The $53bn (£41bn ...

with additional funding from the Wellcome Trust and European Research Council. The Add-Aspirin clinical trial is funded by Cancer Research UK, the National Institute for Health and Care Research ...

Published in the European Journal of Cancer, the study reveals that AI can accurately rule out negative low-dose CT (LDCT) scans, potentially reducing the workload of radiologists by up to 79%.